泰格医药（股票代码：03347）于2026年6月15日发布翌日披露报表，公告显示，公司当日在深圳证券交易所回购A股股份，回购数量为5,313,078股（约531.31万股），占回购前已发行股本约0.7349%。
本次回购每股价格介乎人民币38.84元至39.58元，合计支付约2.08亿元。回购完成后，公司已发行股本（不含库藏股）变动为717,645,592股，库藏股数增至20,255,658股，总股本仍为737,901,250股。
公司确认已遵守香港联合交易所有限公司主板上市规则及当地适用法规。本公告由公司董事叶小平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.